{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:53:13Z","timestamp":1790887993405,"version":"4.1.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.tcm.2010.12.004","type":"journal-article","created":{"date-parts":[[2011,7,10]],"date-time":"2011-07-10T16:45:36Z","timestamp":1310316336000},"page":"153-164","source":"Crossref","is-referenced-by-count":37,"title":["From Atherosclerosis to Acute Coronary Syndromes: The Role of Soluble CD40 Ligand"],"prefix":"10.1016","volume":"20","author":[{"given":"Dimitris","family":"Tousoulis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouel","family":"Androulakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandros","family":"Briasoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Siasos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charalambos","family":"Antoniades","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christodoulos","family":"Stefanadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2010.12.004_bb0005","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1160\/TH05-07-0497","article-title":"Long term influence of regular intake of high dose n-3 fatty acids on CD40-ligand; pregnancy-associated plasma protein A and matrix metalloproteinase-9 following acute myocardial infarction","volume":"95","author":"Aarset\u00f8y","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tcm.2010.12.004_bb0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.amjcard.2003.09.003","article-title":"Increased coronary arterial release of interleukin-1 receptor antagonist and soluble CD40 ligand indicative of inflammation associated with culprit coronary plaques","volume":"93","author":"Aggarwal","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.tcm.2010.12.004_bb0015","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1160\/TH03-05-0268","article-title":"Membrane-associated CD40L and sCD40L in atherothrombotic disease","volume":"90","author":"Anand","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tcm.2010.12.004_bb0020","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nm0302-247","article-title":"CD40L stabilizes arterial thrombi by a b3 integrin-dependent mechanism","volume":"8","author":"Andre","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.tcm.2010.12.004_bb0025","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.atherosclerosis.2009.10.046","article-title":"Effects of rosuvastatin on myeloperoxidase levels in patients with chronic heart failure: a randomized placebo-controlled study","volume":"210","author":"Andreou","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tcm.2010.12.004_bb0030","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/j.jacc.2005.12.057","article-title":"Genetic polymorphisms of platelet glycoprotein Ia and the risk for premature myocardial infarction: effects on the release of sCD40L during the acute phase of premature myocardial infarction","volume":"47","author":"Antoniades","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2010.12.004_bb0035","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1161\/CIRCULATIONAHA.108.843599","article-title":"Preoperative sCD40L levels predict risk of atrial fibrillation after off-pump coronary artery bypass graft surgery","volume":"120","author":"Antoniades","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2010.12.004_bb0040","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1373\/clinchem.2008.102905","article-title":"Assessment of the multiple-biomarker approach for diagnosis of myocardial infarction in patients presenting with symptoms suggestive of acute coronary syndrome","volume":"55","author":"Apple","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.tcm.2010.12.004_bb0045","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/01.CIR.100.6.614","article-title":"Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes","volume":"100","author":"Aukrust","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2010.12.004_bb0050","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1517\/14656566.6.13.2169","article-title":"Potential role for immunomodulatory therapy in atherosclerotic plaque stabilisation","volume":"6","author":"Aukrust","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.tcm.2010.12.004_bb0055","doi-asserted-by":"crossref","first-page":"521.e1","DOI":"10.1016\/j.ahj.2005.10.021","article-title":"Effects of clopidogrel on soluble CD40 ligand and on high-sensitivity C-reactive protein in patients with stable coronary artery disease","volume":"151","author":"Azar","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.tcm.2010.12.004_bb0060","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1161\/01.ATV.0000050143.22910.62","article-title":"Soluble CD40 ligand levels indicate lipid accumulation in carotid atheroma: an in vivo study with high-resolution MRI","volume":"23","author":"Blake","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.tcm.2010.12.004_bb0065","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1365-2796.2007.01810.x","article-title":"Homocysteine-lowering therapy does not affect inflammatory markers of atherosclerosis in patients with stable coronary artery disease","volume":"262","author":"Bleie","year":"2007","journal-title":"J Intern Med"},{"key":"10.1016\/j.tcm.2010.12.004_bb0070","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jacc.2007.10.036","article-title":"Effects of ramipril on endothelial function and the expression of proinflammatory cytokines and adhesion molecules in young normotensive subjects with successfully repaired coarctation of aorta: a randomized cross-over study","volume":"51","author":"Brili","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2010.12.004_bb0075","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ahj.2005.05.004","article-title":"Variants of the CD40 gene but not of the CD40L gene are associated with coronary artery calcification in the Diabetes Heart Study (DHS)","volume":"151","author":"Burdon","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.tcm.2010.12.004_bb0080","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1126\/science.288.5475.2351","article-title":"A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling","volume":"288","author":"Chan","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.tcm.2010.12.004_bb0085","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/biof.62","article-title":"CD40\/CD40L signaling and its implication in health and disease","volume":"35","author":"Chatzigeorgiou","year":"2009","journal-title":"Biofactors"},{"key":"10.1016\/j.tcm.2010.12.004_bb0090","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1182\/blood-2008-03-143479","article-title":"Soluble CD40 ligand induces endothelial dysfunction in human and porcine coronary artery endothelial cells","volume":"112","author":"Chen","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.tcm.2010.12.004_bb0095","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/157488410790410551","article-title":"Hyperhomocysteinemia and cardiovascular risk: effect of vitamin supplementation in risk reduction","volume":"5","author":"Ciaccio","year":"2010","journal-title":"Curr Clin Pharmacol"},{"key":"10.1016\/j.tcm.2010.12.004_bb0100","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1161\/01.ATV.0000182904.08513.60","article-title":"Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis","volume":"25","author":"De Lemos","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.tcm.2010.12.004_bb0105","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.atherosclerosis.2009.03.011","article-title":"Intracoronary versus intravenous abciximab administration in patients with ST-elevation myocardial infarction undergoing thrombus aspiration during primary percutaneous coronary intervention\u2014effects on soluble CD40 ligand concentrations","volume":"206","author":"Dominguez-Rodriguez","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tcm.2010.12.004_bb0110","first-page":"49","article-title":"Outside inside signalling I CD40\u2013mediated B cell activation","volume":"21","author":"D'Orlando","year":"2007","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.tcm.2010.12.004_bb0115","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00395-006-0636-x","article-title":"Functional profile of activated dendritic cells in unstable atherosclerotic plaque","volume":"102","author":"Erbel","year":"2007","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.tcm.2010.12.004_bb0120","first-page":"257","article-title":"Present-day investigations cannot adequately determine the risk of acute coronary syndromes","volume":"47","author":"Foo","year":"2001","journal-title":"Clin Lab"},{"key":"10.1016\/j.tcm.2010.12.004_bb0125","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1016\/j.jacc.2003.12.055","article-title":"Release of soluble CD40L from platelets is regulated by glycoprotein IIb\/IIIa and actin polymerization","volume":"43","author":"Furman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2010.12.004_bb0130","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1538-7836.2005.01124.x","article-title":"GPIIb-IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention","volume":"3","author":"Furman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.tcm.2010.12.004_bb0135","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1136\/heart.86.6.649","article-title":"Patients with acute coronary syndromes express enhanced CD40 ligand\/CD154 on platelets","volume":"86","author":"Garlichs","year":"2001","journal-title":"Heart"},{"key":"10.1016\/j.tcm.2010.12.004_bb0140","first-page":"S554","article-title":"CD40 targeted imaging of atherosclerotic plaque lesions in ApoE \u2212\/\u2212 mice","volume":"118","author":"Grafe","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2010.12.004_bb0145","first-page":"S1030","article-title":"Imaging of atherosclerotic lesions in ApoE \u2212\/\u2212 mice by targeting of CD40","volume":"120","author":"Grafe","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2010.12.004_bb0150","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa022600","article-title":"Soluble CD40 ligand in acute coronary syndromes","volume":"348","author":"Heeschen","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2010.12.004_bb0155","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1109\/IEMBS.2006.260240","article-title":"Soluble CD40L versus myocyte enhancer factor: predicting a prominent marker for cardiovascular disease","volume":"1","author":"Hejase de Trad","year":"2006","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"key":"10.1016\/j.tcm.2010.12.004_bb0160","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/35393","article-title":"CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells","volume":"391","author":"Henn","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.tcm.2010.12.004_bb0165","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1084\/jem.182.1.33","article-title":"Expression of functional CD40 by vascular endothelial cells","volume":"182","author":"Hollenbaugh","year":"1995","journal-title":"J Exp Med"},{"key":"10.1016\/j.tcm.2010.12.004_bb0170","doi-asserted-by":"crossref","first-page":"705","DOI":"10.5551\/jat.3848","article-title":"Switching to aggressive statin improves vascular endothelial function in patients with stable coronary artery disease","volume":"17","author":"Hoshiga","year":"2010","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.tcm.2010.12.004_bb0175","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/1074248409358409","article-title":"Effects of labetalol on hemodynamic parameters and soluble biomarkers of inflammation in acute coronary syndrome in patients with active cocaine use","volume":"15","author":"Hoskins","year":"2010","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.tcm.2010.12.004_bb0180","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1002\/clc.20732","article-title":"Changes in inflammatory biomarkers in patients treated with ticagrelor or clopidogrel","volume":"33","author":"Husted","year":"2010","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.tcm.2010.12.004_bb0185","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1210\/en.2004-1617","article-title":"A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology","volume":"146","author":"Jacobson","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.tcm.2010.12.004_bb0190","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1161\/01.CIR.0000136588.62638.5E","article-title":"Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study","volume":"110","author":"Kinlay","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2010.12.004_bb0195","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1161\/STROKEAHA.107.509844","article-title":"In vivo imaging of the inflammatory receptor CD40 after cerebral ischemia using a fluorescent antibody","volume":"39","author":"Klohs","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.tcm.2010.12.004_bb0200","first-page":"495","article-title":"Sustained elevation of serum CD40 ligand levels one month after coronary angioplasty predicts angiographic restenosis","volume":"21","author":"L'Allier","year":"2005","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.tcm.2010.12.004_bb0205","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.jacc.2008.07.032","article-title":"CD40 ligand microparticles from human atherosclerotic plaques stimulate endothelial proliferation and angiogenesis a potential mechanism for intraplaque neovascularization","volume":"52","author":"Leroyer","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2010.12.004_bb0210","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0021-9150(03)00012-1","article-title":"Circulating markers of inflammation and atherosclerosis","volume":"169","author":"Lind","year":"2003","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tcm.2010.12.004_bb0215","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1038\/15271","article-title":"Requirement for CD154 in the progression of atherosclerosis","volume":"5","author":"Lutgens","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/j.tcm.2010.12.004_bb0220","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1084\/jem.20091293","article-title":"Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile","volume":"207","author":"Lutgens","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/j.tcm.2010.12.004_bb0225","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/28204","article-title":"Reduction of atherosclerosis in mice by inhibition of CD40 signalling","volume":"394","author":"Mach","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.tcm.2010.12.004_bb0230","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1161\/01.ATV.0000222908.78873.36","article-title":"Soluble CD40L levels are regulated by the \u22123459 A > G polymorphism and predict myocardial infarction and the efficacy of antithrombotic treatment in non\u2013ST elevation acute coronary syndrome","volume":"26","author":"M\u00e4larstig","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.tcm.2010.12.004_bb0235","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0300-8932(09)71335-1","article-title":"Biomarkers in cardiovascular medicine","volume":"62","author":"Mart\u00edn-Ventura","year":"2009","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.tcm.2010.12.004_bb0240","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1161\/01.CIR.0000069272.06194.91","article-title":"Effect of rosiglitazone treatment on soluble CD40L in patients with type 2 diabetes and coronary artery disease","volume":"107","author":"Marx","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2010.12.004_bb0245","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jlb.63.3.373","article-title":"CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin expression","volume":"63","author":"Miller","year":"1998","journal-title":"J. Leukoc Biol"},{"key":"10.1016\/j.tcm.2010.12.004_bb0250","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1161\/01.CIR.0000124581.18191.15","article-title":"Atorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromes","volume":"109","author":"Mitsios","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2010.12.004_bb0255","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1093\/eurheartj\/ehp301","article-title":"Effect of irbesartan and enalapril in non\u2013ST elevation acute coronary syndrome: results of the randomized; double-blind ARCHIPELAGO study","volume":"30","author":"Montalescot","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2010.12.004_bb0260","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/eurheartj\/ehn071","article-title":"Concurrent evaluation of novel cardiac biomarkers in acute coronary syndrome: myeloperoxidase and soluble CD40 ligand and the risk of recurrent ischaemic events in TACTICS-TIMI 18","volume":"29","author":"Morrow","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2010.12.004_bb0265","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/01.CIR.0000053559.46158.AD","article-title":"Inhibitory effects of glycoprotein IIb\/IIIa antagonists and aspirin on the release of soluble CD40 ligand during platelet stimulation","volume":"107","author":"Nannizzi-Alaimo","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2010.12.004_bb0270","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1097\/MBC.0b013e328329f28c","article-title":"Elevations in soluble CD40 ligand in patients with high platelet aggregability undergoing percutaneous coronary intervention","volume":"20","author":"Obradovic","year":"2009","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.tcm.2010.12.004_bb0275","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11239-007-0156-z","article-title":"Lack of association between soluble CD40L and risk in a large cohort of patients with acute coronary syndrome in OPUS TIMI-16","volume":"26","author":"Olenchock","year":"2008","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.tcm.2010.12.004_bb0280","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1086\/316902","article-title":"Two loci on chromosomes 2 and X for premature coronary heart disease identified in early- and late-settlement populations of Finland","volume":"67","author":"Pajukanta","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.tcm.2010.12.004_bb0285","first-page":"250","article-title":"The impact of statin administration in acute coronary syndromes","volume":"51","author":"Papageorgiou","year":"2010","journal-title":"Hellenic J Cardiol"},{"key":"10.1016\/j.tcm.2010.12.004_bb0290","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.thromres.2009.06.021","article-title":"Prior simvastatin treatment is associated with reduced thrombin generation and platelet activation in patients with acute ST-segment elevation myocardial infarction","volume":"125","author":"Pastuszczak","year":"2010","journal-title":"Thromb Res"},{"key":"10.1016\/j.tcm.2010.12.004_bb0295","doi-asserted-by":"crossref","first-page":"12367","DOI":"10.1073\/pnas.2032886100","article-title":"Soluble CD40 ligand induces beta3 integrin tyrosine phosphorylation and triggers platelet activation by outside-in signaling","volume":"100","author":"Prasad","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tcm.2010.12.004_bb0300","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1016\/j.jacc.2007.02.044","article-title":"Homocysteine modulates the CD40\/CD40L system","volume":"49","author":"Prontera","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2010.12.004_bb0305","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4244\/V5I3A52","volume":"5","author":"Ray","year":"2009","journal-title":"EuroIntervention"},{"key":"10.1016\/j.tcm.2010.12.004_bb0310","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.molmed.2008.09.006","article-title":"CD40-CD40 ligand interactions in oxidative stress, inflammation and vascular disease","volume":"14","author":"Rizvi","year":"2008","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.tcm.2010.12.004_bb0315","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000106683","article-title":"Soluble CD40 ligand as a predictor of coronary artery disease and long-term clinical outcomes in stable patients undergoing coronary angiography","volume":"109","author":"Rondina","year":"2008","journal-title":"Cardiology"},{"key":"10.1016\/j.tcm.2010.12.004_bb0320","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1007\/s11739-007-0076-0","article-title":"CD40\/CD40L system and vascular disease","volume":"2","author":"Santilli","year":"2007","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.tcm.2010.12.004_bb0325","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1161\/hh2401.101272","article-title":"CD40 signaling and plaque instability","volume":"89","author":"Sch\u00f6nbeck","year":"2001","journal-title":"Circ Res"},{"key":"10.1016\/j.tcm.2010.12.004_bb0330","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/PL00000776","article-title":"The CD40\/CD154 receptor\/ligand dyad","volume":"58","author":"Sch\u00f6nbeck","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.tcm.2010.12.004_bb0335","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1073\/pnas.97.13.7458","article-title":"Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice","volume":"97","author":"Sch\u00f6nbeck","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tcm.2010.12.004_bb0340","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1160\/TH08-12-0805","article-title":"The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist; on platelet biomarkers in healthy volunteers and patients with coronary artery disease","volume":"102","author":"Serebruany","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.tcm.2010.12.004_bb0345","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.atherosclerosis.2005.03.051","article-title":"Leukocyte CD40L deficiency affects the CD25(+) CD4 T cell population but does not affect atherosclerosis","volume":"183","author":"Smook","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.tcm.2010.12.004_bb0350","doi-asserted-by":"crossref","first-page":"509","DOI":"10.2174\/157016110791330870","article-title":"Inflammatory markers in essential hypertension: potential clinical implications","volume":"8","author":"Stefanadi","year":"2010","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.tcm.2010.12.004_bb0355","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/clc.20254","article-title":"Clinical implications of elevated serum interleukin-6, soluble CD40 ligand, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in patients with acute ST-segment elevation myocardial infarction","volume":"31","author":"Tan","year":"2008","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.tcm.2010.12.004_bb0360","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.biopha.2009.09.021","article-title":"A common polymorphism in CD40 Kozak sequence (\u22121C\/T) is associated with acute coronary syndrome","volume":"64","author":"Tian","year":"2010","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.tcm.2010.12.004_bb0365","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cytogfr.2006.04.003","article-title":"Pro-inflammatory cytokines in acute coronary syndromes: from bench to bedside","volume":"17","author":"Tousoulis","year":"2006","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.tcm.2010.12.004_bb0370","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2362.2007.01834.x","article-title":"Interaction between cytokines and sCD40L in patients with stable and unstable coronary syndromes","volume":"37","author":"Tousoulis","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.tcm.2010.12.004_bb0375","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1136\/hrt.2006.088211","article-title":"Assessing inflammatory status in cardiovascular disease","volume":"93","author":"Tousoulis","year":"2007","journal-title":"Heart"},{"key":"10.1016\/j.tcm.2010.12.004_bb0380","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1136\/hrt.2008.152736","article-title":"Effective platelet inhibition by aspirin and clopidogrel: where are we now?","volume":"95","author":"Tousoulis","year":"2009","journal-title":"Heart"},{"key":"10.1016\/j.tcm.2010.12.004_bb0385","first-page":"441","article-title":"Endothelial function and inflammation in coronary artery disease","volume":"92","author":"Tousoulis","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.tcm.2010.12.004_bb0390","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.2174\/092986708784534965","article-title":"New biochemical markers in acute coronary syndromes","volume":"15","author":"Tousoulis","year":"2008","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.tcm.2010.12.004_bb0395","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.pharmthera.2010.05.001","article-title":"Recent therapeutic approaches to platelet activation in coronary artery disease","volume":"127","author":"Tousoulis","year":"2010","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.tcm.2010.12.004_bb0400","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1182\/blood-2008-07-167411","article-title":"Systemic blood coagulation activation in acute coronary syndromes","volume":"113","author":"Undas","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.tcm.2010.12.004_bb0405","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1161\/01.CIR.0000088521.04017.13","article-title":"Soluble CD40L risk prediction after acute coronary syndromes","volume":"108","author":"Varo","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2010.12.004_bb0410","first-page":"37","article-title":"Early use of gemfibrozil in patients with non ST Elevation acute coronary syndrome. Changes of markers of inflammation and von Willebrand factor","volume":"46","author":"Vaulin","year":"2006","journal-title":"Kardiologiia"},{"key":"10.1016\/j.tcm.2010.12.004_bb0415","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.clinthera.2006.06.010","article-title":"Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels","volume":"28","author":"Vavuranakis","year":"2006","journal-title":"Clin Ther"},{"key":"10.1016\/j.tcm.2010.12.004_bb0420","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1345\/aph.1D611","article-title":"CD40 ligand: a novel target in the fight against cardiovascular disease","volume":"38","author":"Vishnevetsky","year":"2004","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.tcm.2010.12.004_bb0425","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2362.2009.02237.x","article-title":"High-dose tirofiban with enoxaparin and inflammatory markers in high-risk percutaneous intervention","volume":"40","author":"Walters","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.tcm.2010.12.004_bb0430","doi-asserted-by":"crossref","first-page":"E55","DOI":"10.1002\/clc.20667","article-title":"The Relationship between CD40 gene polymorphism and unstable coronary atherosclerotic plaques","volume":"33","author":"Wang","year":"2010","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.tcm.2010.12.004_bb0435","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1002\/clc.26","article-title":"Transcoronary concentration gradient of sCD40L and hsCRP in patients with coronary heart disease","volume":"30","author":"Wang","year":"2007","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.tcm.2010.12.004_bb0440","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/10976640600737649","article-title":"Myocardial perfusion reserve in cardiovascular magnetic resonance: correlation to coronary microvascular dysfunction","volume":"8","author":"W\u00f6hrle","year":"2006","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.tcm.2010.12.004_bb0445","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF02256091","article-title":"The role of CD40-CD154 interaction in cell immunoregulation","volume":"11","author":"Xu","year":"2004","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.tcm.2010.12.004_bb0450","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s10238-010-0092-7","article-title":"Association analysis of CD40 gene polymorphism with acute coronary syndrome","volume":"10","author":"Yan","year":"2010","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.tcm.2010.12.004_bb0455","first-page":"491","article-title":"Clinical implications of increased expression of CD40L in patients with acute coronary syndromes","volume":"115","author":"Yan","year":"2002","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.tcm.2010.12.004_bb0460","first-page":"251","article-title":"Relation between upregulation of CD40 system and complex stenosis morphology in patients with acute coronary syndrome","volume":"25","author":"Yan","year":"2004","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.tcm.2010.12.004_bb0465","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cccn.2004.01.012","article-title":"The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes","volume":"343","author":"Yan","year":"2004","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.tcm.2010.12.004_bb0470","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1161\/CIRCULATIONAHA.106.683201","article-title":"CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1","volume":"115","author":"Zirlik","year":"2007","journal-title":"Circulation"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173810001611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173810001611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T21:53:49Z","timestamp":1560376429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173810001611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":94,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S1050173810001611"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2010.12.004","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}